What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2021-03-17 compared with 2020-12-18 · 20 added, 34 removed, 6 unchanged (90% of the section changed)

Other Information

On May 18, 2020 and May 19, 2020, pursuant

to the Nevada Revised Statutes and the Bylaws of the Company, the Board of Directors of the Company and the stockholders holding

a majority of 50.3% of the Company’s outstanding voting outstanding capital stock, respectively, approved the filing of an

amendment to the Articles of Incorporation of the Company to increase the authorized amount of common stock from 750,000,000 to

1,500,000,000, without changing the par value of the common stock or authorized number and par value of “blank check”

February 9, 2021, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary

of State of Nevada to increase the authorized amount of common stock from 1,500,000,000 to 2,500,000,000, without changing the

par value of the common stock or authorized number and par value of “blank check”

Preferred Stock.

On June 2, 2020, the Company filed a Definitive 14C with the SEC regarding the corporate action.

On June 24, 2020,

the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of State of Nevada

to effectuate the corporate action on June 24, 2020.

Certificate of Amendment to the Articles of Incorporation filed with the Secretary of State of Nevada on February 10, 2021, effective February 9, 2021.

Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer

2 unchanged sentences

Section 1350 Certification of Principal Financial and Accounting Officer

XBRL Instance Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Labels Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Filed herewith.

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under those sections.

All of the Exhibits

are available from the SEC’s website at www.sec.gov.

In addition, the Company will furnish a copy of any Exhibit upon payment

of a fee (based on the estimated actual cost which shall be determined at the time of the request) together with a request addressed

to Albert Mitrani, Organicell Regenerative Medicine Inc., 4045 Sheridan Ave, Suite 239, Miami, FL 33140.

Pursuant to the requirements of Section

13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the

undersigned, thereunto duly authorized.

ORGANICELL REGENERATIVE MEDICINE, INC.

/s/ ALBERT MITRANI

Instance Document

Taxonomy Extension Schema Document

Taxonomy Extension Calculation Linkbase Document

Taxonomy Extension Labels Linkbase Document

Taxonomy Extension Definition Linkbase Document

Taxonomy Extension Presentation Linkbase Document

to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus

for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities

Exchange Act of 1934 and otherwise are not subject to liability under those sections.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report

to be signed on its behalf by the undersigned, thereunto duly authorized.

REGENERATIVE MEDICINE, INC.

ALBERT MITRANI

Chief Executive Officer

(Principal Executive Officer)

December 17, 2020

Chief Financial Officer

(Principal Financial and Accounting Officer)

December 17, 2020

Executive Officer

Executive Officer)

Financial Officer

Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information